EDGAR Filing Documents for 0001104659-21-009669

Form 8-K - Current report:

SEC Accession No. 0001104659-21-009669

Filing Date

2021-02-01

Accepted

2021-02-01 06:55:17

Documents

Period of Report

2021-01-29

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm214779d1_8k.htm	8-K	29493
2	EXHIBIT 10.1	tm214779d1_ex10-1.htm	EX-10.1	61058
3	EXHIBIT 10.2	tm214779d1_ex10-2.htm	EX-10.2	29921
4	EXHIBIT 10.3	tm214779d1_ex10-3.htm	EX-10.3	59987
5	EXHIBIT 99.1	tm214779d1_ex99-1.htm	EX-99.1	12228
6	EXHIBIT 99.2	tm214779d1_ex99-2.htm	EX-99.2	11046
	Complete submission text file	0001104659-21-009669.txt		205007

Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452

Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043

EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)